Launch a DUTCH Hormone-Panel Diagnostic Testing Service

A diagnostics business in the hormone-therapy chain. Clinical best practice requires proper hormone testing before starting a protocol and again on the 3-to-6-month reassessment cadence, and the DUTCH panel plus standard bloodwork is the infrastructure that supports it. You supply that testing, either by reselling established panels through a certified lab partner and handling collection, logistics, and results delivery, or by operating your own certified testing capacity. Your customers are hormone clinics that want reliable diagnostics and informed patients seeking their own baseline data.

You sell directly into the category's number-one failure mode. The research is explicit that dosing without adequate testing (particularly DUTCH testing) and without inflammation and cortisol evaluation is the leading cause of poor HRT outcomes and churn, and that the Endocrine Society and North American Menopause Society recommend reassessment every 3 to 6 months in the first year. That means recurring test demand per patient, not a one-time sale: a baseline panel plus follow-ups on a schedule. Serving many clinics plus direct-to-patient buyers diversifies demand. Margins of 40 to 60 percent are consistent with a diagnostics-service layer. All figures vary by model and are not income promises.

Testing reads as a background commodity, so few connect it to the fact that inadequate testing is the documented root cause of hormone-therapy failure. The category also assumes clinics already have labs handled, when many independent practices want a reliable, hormone-specific testing partner that makes proper baseline and reassessment testing easy. And because you can enter as a reseller-and-logistics service rather than a full certified lab, the barrier is lower than the word laboratory implies, though real certification requirements apply if you test in-house.